Corporate Banner
Satellite Banner
Technology Networks Header
Friday, April 18, 2014
Technology Networks
 
Register | Sign in
Home Page>White Papers

  White Papers

A Scientific Approach to Good Manufacturing Practices

AMRI
More information
Bile Acids: Beyond Cholesterol Metabolism & Fat Absorption

Pacific Biomarkers
More information
Carbonylation using carbon monoxide: Novasep’s shortcut to complex str

Novasep Inc
More information
Competitive Edge

AMRI
More information
Evolving Intelligence

AMRI
More information
Expedite Development While Ensuring Successful Commercial Outcomes

AMRI
More information
Medical Affairs at the Centre of Life Sciences Innovation

Kinapse
More information
NonClinical Dose Formulation Analysis Method Validation and Sample Ana

SpringerLink
More information
Product Lifecycle Management: Maximizing profit and leveraging innovat

Vetter Pharma International GmbH
More information
<< 1 2 3 >>
showing results 1 to 9 of 19
Scientific News
Domainex Programme Shows Great Promise for the Treatment of Inflammatory Diseases
Company’s IKKe/TBK1 programme to offer a disease-modifying treatment for COPD patients.
Drug Does Not Improve Set of Cardiovascular Outcomes for Diastolic Heart Failure
NIH-supported study finds drug does appear to reduce hospitalizations for diastolic heart failure.
Blocking DNA Repair Mechanisms Could Improve Brain Cancer Therapy
The findings were published April 7 in Nature Communications.
Aspirin Does Not Prevent Pregnancy Loss, NIH Study Finds
Increased live birth rate in subgroup of participants.
Statins Slow the Progression of Advanced MS in Clinical Trial
The work is published in the Lancet.
Researchers Discover Underlying Genetics, Marker for Stroke, Cardiovascular Disease
NIH-funded findings point to new potential strategies for disease prevention, treatment.
New Clinical Study on the Relationship Between Imaging and OVA1®
New analysis explores interactions between clinical risk factors used in pre-surgical assessment.
Statins Slow the Progression of Advanced MS in Clinical Trial
The work is published in the Lancet.
Sepsis Study Comparing Three Treatment Methods Shows Same Survival Rate
NIH-funded clinical trial tested specific protocols against usual high-level care.
New Trial of Personalized Cancer Treatment Begins in Oxford
Phase I trial in Oxford will investigate a new drug, called CXD101.
Scroll Up
Scroll Down
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv